The company says industry estimates are that 12 million accessible breeding ewes (91%) are not vaccinated against enzootic abortion in the UK, and that this should concern all practitioners with sheep clients.
Any flock with an abortion rate of over 2% could, it says, be suffering from the disease, and at a cost of £85 per aborted ewe, those are losses producers can ill-afford to ignore.
Stephenie Clarke from Ceva said: "Abortion remains one of the most significant reasons for loss in sheep flocks and an abortion storm can lead to crippling results on farm.
"Enzootic abortion caused by C. abortus remains the main cause of ovine abortion in the UK1 and once in a flock, takes time to control as exposed ewes can become latently infected."
Assure Ewe is a subsidised blood testing scheme open to all flocks with 50 or more breeding ewes. In contrast to other schemes, evidence of an abortion does not need to have taken place.
Blood samples should be collected from six ewes, with full farm and vet details also supplied. Upon results, Ceva says it will share information with the participating veterinary surgeon to discuss with the farmer.
Stephenie added: "Assure Ewe is a very user-friendly, simple scheme that will help facilitate conversations between vets and farmers while, at the same time, providing useful testing information to vets. Ceva encourages evidence based veterinary decisions, and this is just one example of such an initiative."
If C. abortus is identified in a flock, a veterinary-devised plan combining vaccination with Cevac Chlamydia, biosecurity and only purchasing stock from accredited flocks will assist disease control and eventual eradication.
For further information about the scheme, contact your Ceva territory manager.
Reference
Metaxol contains 20 mg trimethoprim and 100 mg sulfamethoxazole per ml and can be added directly to drinking water or used in a concentrated stock.
The new product, which is part of the company's SoluStab range, replaces Methoxasol. Dechra says it is likely to be welcomed by farmers wanting to target entire flocks because of its shorter withdrawal time for broilers.
Dechra Brand Manager Emma Jennings said: "Sulfamethoxazole is a potent sulfonamide and, when combined with trimethoprim, it has a synergistic and bactericidal effect.
"Both active ingredients are rapidly absorbed and distributed widely in tissues making it a highly effective treatment.
"The shorter withdrawal time for broilers will make it an attractive treatment for farmers wanting to target entire flocks."
Metaxol is not suitable for laying hens.
In fattening pigs, Metaxol is suitable for the treatment and metaphylaxis of post-weaning diarrhoea caused by beta-haemolytic K88-positive, K99-positive or 987P Escherichia coli strains susceptible to trimethoprim-sulfamethoxazole.
It can also be used for secondary bacterial infections caused by Pasteurella multocida, Actinobacillus pleuropneumoniae, Streptococcus spp. and Haemophilus parasuis susceptible to trimethoprim-sulfamethoxazole.
In broilers, it can be used for treatment and metaphylaxis of Colibacillosis caused by Escherichia coli susceptible to trimethoprim-sulfamethoxazole or Coryza caused by Avibacterium paraga.
The recommended dosage is 0.25 ml of product per kg body weight per day for four to seven days for pigs and 0.38 ml of product per kg body weight per day for three days for chickens.
For support in calculating dosages, visit http://calculator.solustab.eu/.
A 3 km Protection Zone and a 10 km Surveillance Zone have been put in place around the infected premises to limit the risk of the disease spreading.
The infected flock contains nine birds. Defra says a number had died and the remaining live birds at the premises are being humanely culled. A full investigation is under way to determine the source of the infection.
Full details of the control measures in place can be found here.
The recommendation follows the analysis of data collected as part of the company's Talk About Laminitis disease awareness initiative, which has seen more than 47,000 horses tested for PPID since it was launched in 20121.
The data revealed that, regardless of presenting clinical signs, a horse aged 15-20 is three times more likely to have PPID compared to a horse under 10, and this risk increases with age. For example, a horse of 20-25 is six times more likely to have PPID compared to a horse under 10 and a horse that is 25-30 is 10 times more likely to have PPID.
Boehringer says that despite the high prevalence of PPID in the older horse population, the clinical signs of the disease are insidious in onset and owners may simply associate them with the ageing process.
One study demonstrated that in a single population of horses over the age of 15 only 1.6% of owners reported signs of PPID2. However, when the same group of horses were examined by a veterinary surgeon, 21% were found to have signs of the disease.
Dr Jo Ireland, veterinary surgeon at the University of Liverpool, said: "It is often difficult for owners to spot the signs of PPID as they frequently associate them with the ageing process. However, PPID is now the fifth most commonly diagnosed disease in horses in the UK3.
"We are therefore encouraging veterinary surgeons to routinely test horses over 15 years of age or those that are displaying signs of PPID with an ACTH test."
The 'Talk About Laminitis' disease awareness initiative runs from June until the end of October and aims to raise awareness of the underlying hormonal causes of laminitis – PPID and Equine Metabolic Syndrome (EMS). As part of the scheme, the laboratory fees for the blood test which detects PPID (the basal ACTH test) are free.
Redwings’ head of veterinary and care, senior veterinary surgeon Nicky Jarvis, said: "Any initiative that decreases the incidence of laminitis developing in an older equine is invaluable. Laminitis is an extremely distressing condition for both the horse and the owner and the long-term consequences can be devastating. Knowing the underlying cause is a huge help in tackling the disease and we would encourage anyone to take advantage of this offer and get their veteran checked out."
For further information about 'Talk About Laminitis', visit www.talkaboutlaminitis.co.uk or contact your local Boehringer Ingelheim account manager.
References
In 2014 ioLight co-founders, Oxford physicists Andrew Monk and Richard Williams, filed a patent application for a pocket-sized digital microscope with a performance that compares with expensive laboratory microscopes. They asked Cambridge Industrial Design to realise the product, briefing them that the device would need to deliver images with one micron resolution (required to view human or animal cells) onto a smartphone or tablet, be pocket-sized, easy to use, and economical to build in medium to high volumes.
One of the biggest challenges was in making the unit pocket-sized, which meant it had to be foldable, something which could have led to a loss in the rigidity needed to achieve high resolution images. This challenge was overcome with the use of a single hinge which the company says makes the ioLight both portable and robust.
Alex Jones, Managing director of Cambridge Industrial Design said: "We recognised immediately this was a great idea but the design brief was certainly a challenge. Fortunately, challenges can sometimes bring out the best in designers. The final design is a real success both aesthetically and ergonomically, and this award is a fantastic acknowledgement for the design process and the final product that we have created together with ioLight."
ioLight is also celebrating another success: closing its second round of equity funding after raising £320k from 335 investors on the Crowdcube platform (128% of the initial target).
The company says the new funding will allow it to promote the microscope to a wide range of target markets including veterinary surgeons, education, laboratory and field research, museums and public engagement as well as to international markets.
Andrew Monk, ioLight’s co-founder said: "The product is so simple to use that it is the ideal communication tool for explaining science to the public, students and customers. The microscope lets everyone see the same image so the discussion is about the picture not the tools. It’s a perfect fit for government public engagement campaigns, which are well funded at the moment. We are absolutely delighted that this funding provides us with the opportunity for both product development and to reach out and make microscopy available to so many more people."
Severn Edge was formed six years ago with the merger of two long-standing neighbouring practices, and now employs 135 people, including 43 veterinary surgeons.
Mrs Karyn MacKenzie, Director of CVS’ Practice Division, said: "Severn Edge is an impressive practice with an outstanding leadership team and an ambitious and exciting vision for the future which we share. We are delighted to welcome the team to CVS and look forward to working with them to help them build an even more successful future."
Dr John Brentnall BVSc MRCVS, a Director of Severn Edge, will continue in the role of CVS Regional Director. He said: "It was clear from our early discussions that CVS understood what we are trying to achieve. We have embarked on a significant investment programme, including upgrading our surgery at Madeley outside Telford, and the redevelopment of the site of an additional clinic which we have recently acquired in Craven Arms.
"In order for us to continually upgrade our clinics, provide the widest range of career opportunities for our staff and steer our practice through an increasingly competitive world, we believe that the best interests of us all lie in joining forces with CVS. It is known for its interest in equine and farm practice, as well as companion animal practice, and has a policy of significant investment in both infrastructure and staff. We believe it offers the best fit with Severn Edge."
Chris Tufnell, current President of the RCVS, said: "We are very sad to hear of the death of Lord Soulsby of Swaffham Prior, a figure who had a truly exceptional career, unique in its achievements and one dedicated to bridging and bringing together the worlds of medical and veterinary science.
"His dedication to the concept of One Health is demonstrated by the fact that, during his life time, he was both President of the Royal College of Veterinary Surgeons (from 1984-85) and the Royal Society of Medicine (1998-2000), the first veterinary surgeon to be elected to that position, as well as being a founding Fellow of the Academy of Medical Sciences.
"He was the recipient of numerous honorary degrees and prizes including Honorary Fellowship of the College and, at RCVS Day in 2015, received the Queen’s Medal, the highest award that the RCVS can bestow upon a veterinary surgeon. This was given in recognition of his contribution to One Health but also his international work as a Fellow and Professor in numerous countries across the world and his political work as the first veterinary surgeon to enter the House of Lords in 1990.
"He gave an outstanding service to the profession, to veterinary science and to animal welfare but was known for his endearing personality as much as his intellect. He will be missed by many colleagues in the veterinary world but his legacy will live on through inspiring veterinary surgeons from all walks of life to work more closely with other healthcare and medical professionals and through his numerous published books and papers. Our sympathies are with his family and friends."
Photo: Lord Soulsby getting a standing ovation at RCVS Day 2015. Courtesy RCVS.
Dechra says necrotic enteritis can be treated with a variety of therapeutic antibiotics but that the first choice antibiotics¹ for treatment are narrow spectrum antibiotics, like phenoxymethylpenicillin.
Phenocillin is an 800 mg/g powder for use in drinking water. It is lactose free, and Dechra says its high solubility makes it ideal for concentrated stock solutions and convenient for modern poultry farming. There is a zero withdrawal time so egg production is unaffected.
Dechra Brand Manager Emma Jennings said: “Necrotic enteritis is the most common bacterial disease in modern broiler flocks that can be financially devastating for farmers.
"The high concentration means easy dosage and handling with less waste and the lactose free formula reduces the risk of biofilm development resulting in a high quality and effective product, supporting the responsible use of antimicrobials.
"Phenocillin is a highly effective treatment and we anticipate it will become the preferred solution for veterinary professionals and end users to treat this disease that can very suddenly devastate broiler flocks."
For more information, visit: http://bit.ly/2nAboGU
BVA Scottish Branch President Grace Webster said: "We commend the Scottish Government on seizing the opportunity to improve animal welfare through the introduction of a Bill to ban of the use of wild animals in travelling circuses. While the use of wild animals in travelling circuses may not affect a great number of individual animals, it is emblematic of the way we treat all animals and we would urge the rest of the UK to follow this precedent, introduced on ethical grounds.
"However, this package of measures seems a bit of a mixed bag. Until recently Scotland also led the way on dog welfare with a complete ban on tail docking, so we are extremely disappointed at the decision to reverse this stance. We have carefully considered all the evidence and remain convinced that tail docking in dogs, even specific breeds, is detrimental to their welfare. This is a retrograde step for animal welfare in Scotland, amidst an otherwise progressive package of animal welfare measures."
At the end of May, BVA Scottish Branch Junior Vice President Melissa Donald will be giving evidence to the Environment Committee in the Scottish Parliament ahead of a vote on whether or not to approve the change in law relating to tail docking.
Today’s announcement by the Cabinet Secretary for Environment, Climate Change and Land Reform Roseanna Cunningham MSP also included the introduction of controls to restrict the use of electronic training collars and a commitment to update regulations to combat the irresponsible breeding and sale of dogs, cats and rabbits.
Gudrun Ravetz, BVA President, added: "Animal welfare starts right at the beginning of a pet’s life, so the focus on pet licensing and breeding regulations is welcome. We know that a third of vets are seeing puppies they believe to have been illegally imported and an increasing number of owners are buying brachycephalic or designer breeds, like Scottish fold cats; pets must be purchased with owners prioritising animal health and welfare, rather than making an impulse buy based on looks alone.
"Yet we are saddened at the shortfall on legislation around aversive training aids for dogs, which we expect will still permit the use of training collars under expert guidance. We know using fear as a training tool is not only less effective than positive reinforcement, but can take its toll on a dog’s overall welfare. Without an outright ban, we have grave concerns over how enforceability will work. This raft of measures seems to give with one hand and take away with the other."
To be entered into the prize draw, you need to view three short webinars on feline chronic kidney disease (CKD) on the Boehringer Academy website – www.boehringer-academy.co.uk.
The online seminars, which each last for approximately 20-30 minutes, count towards CPD and are as follows:
Tuesday 20 June at 7.30pmThe role of IDEXX SDMA in early diagnosis of feline CKDLearn how you can detect feline CKD earlier and more reliably with the IDEXX SDMA blood testSusan Randell, Head of Internal Medicine at IDEXX Laboratories
Tuesday 4 July at 7.30pmThe importance of early diagnosis in feline CKDUnderstand the importance of early diagnosis in cases of CKD and the impact this can have on progression of the diseaseSarah Caney, RCVS Recognised Specialist in Feline Medicine
Tuesday 18 July at 7.30pmThe balanced approach to feline CKDDiscover more about the balanced approach to managing the progression of feline CKDSarah Caney, RCVS Recognised Specialist in Feline Medicine
The three-day ISFM congress takes place at Le Méridien Phuket Beach Resort from 7-9 November. The congress will explore the latest developments in feline medicine and keynote speakers, Carolyn O’Brien and Jessica Quimby, will cover a range of current and challenging feline medicine topics. Local speakers complement the varied programme, which aims to offer practical hints and tips for delegates to take back and use in clinic.
The prize includes flights, transfers and bed and breakfast accommodation for two people for three nights in Phuket, as well as two delegate tickets to the ISFM congress. The prize draw will take place w/c 14 August.
To enter, watch all three new Semintra webinars on the Boehringer Academy website: www.boehringer-academy.co.uk.
According to the company, information on best worming strategies for foals and yearlings remains largely anecdotal, making it difficult to develop a clear plan for this age group. Zoetis veterinary surgeon Wendy Talbot has therefore reviewed the recent literature to develop an eight-point plan.
Explaining the guidance, Wendy writes:
Foals and yearlings are usually more susceptible to worms than are adult horses because they have had little chance to develop any immunity. They are more vulnerable to related diseases and tend to have higher egg shedding, which increases the risk of infection. The main parasitic culprits in the UK for foals less than six months of age are large roundworms (ascarids). In older foals and weanlings, small and large strongyles, tapeworms (and pinworms) are the main considerations.1 Yearlings may also have a second wave of large roundworm infection at 8-10 months of age.2 Any control strategy will need to take into account the individual circumstances such as stocking density, pasture management and previous disease history.
Guidelines for parasite control in foals suggest a first treatment with fenbendazole at 2-3 months of age, targeting large roundworm, followed by another treatment at 5-6 months. Alternatively, pyrantel may be considered for these doses; however, there may be resistance in some areas and foals with large adult ascarid burdens may be at higher risk of intestinal rupture when this drug is used.4 At weaning (approximately six months of age), it is advisable to perform a faecal worm egg count (FWEC) to determine if treatment for strongyles is also required; the macrocyclic lactone anthelmintics (ivermectin or moxidectin) are expected to have the highest efficacy. At 9 and 12 months of age treatment for stronglyes and a larvicidal dose for encysted stages of small strongyles (moxidectin or a 5 day course of fenbendazole) are indicated. A tapeworm treatment should be included with one of these doses.2,3
For yearlings, two methods have recently been proposed for worm control: the first involves using faecal worm egg counts (FWECs) at more frequent intervals than for adults to guide dosing for strongyles in the grazing season.1 The second suggests three baseline treatments targeting strongyles in spring, summer and late autumn, with FWECs in between to identify and treat any still shedding high numbers of eggs, up to a maximum of six treatments per year.2 Macrocyclic lactones have the highest expected efficacy against small strongyles and should form the basis of treatments; however, pyrantel can be considered for some treatments where it has been shown to have continued efficacy. Both strategies include a larvcidal treatment for encysted small redworm combined with testing or treating for tapeworm in late autumn. The inclusion of one or two doses of a macrocyclic lactone each year (usually already used for small strongyle control) should be sufficient to prevent large strongyle related disease.3
The wide differences in the circumstances of foals and yearlings, together with geographical variations in resistance patterns and a lack of consensus on best practice in this group means it is not possible to define a single approach to a worming plan. An important point to note is that FWECs may give surprising results because higher counts are generally seen in youngstock.
Eight ways to keep clients' youngstock worms controlled:
For further information on worming together with some equine specific CPD visit: https://blog.vetsupportplus.com/
The existing MSD Animal Health Connect Bursary and Ruminant Research Bursary have been combined into the new MSD Animal Health Research Bursary which is designed to support the future of the veterinary profession through research.
The student arm of the new Research Bursary will award £1,000 to the five best research project applications received from veterinary students across all UK veterinary schools, with an opportunity for an additional £1,000 top prize and £500 runner-up prize.
The veterinary surgeon arm of the Research Bursary will offer three awards, consisting of two ruminant awards and one companion animal award, of up to £4,000 each. The veterinary practitioner proposals will be judged by University academics to ensure independent assessment.
Michelle Townley, Veterinary Advisor at MSD Animal Health said: "Our existing Research Bursaries are well known amongst students and practitioners, having run for over 25 years for the student bursary and 6 years for the ruminant bursary. To increase our support for the veterinary profession through research we have decided to combine our Research Bursaries and add some new categories to help appeal to as wide an audience as possible. This way we can offer a broader level of support for both existing companion animal and ruminant practitioners and our veterinary surgeons of the future. We aim to engage as many people as possible so the MSD Animal Health Research Bursary will be supported by a new website page and social media package to encourage as much interest from students and practitioners as possible."
Student bursary applications are now invited, with a deadline for entries of Friday 26th May 2017. Veterinary practitioners will be invited to apply in September 2017.
For further details go to the MSD Animal Health Research Bursary website at www.msd-animal-health.co.uk/researchbursary.aspx.
Prior to joining Fitzpatrick Referrals, Gerard was a Senior Lecturer in Internal Medicine at the University of Glasgow as well as Head of the Emergency Service and Director of both the Internship and ECVIM Residency Programmes. He is also a European and Royal College Recognised Specialist in Internal Medicine, and recently became one of few specialists in the world to have completed a 12 month Fellowship in Interventional Radiology at the Animal Medical Center in New York.
Gerard said: "When I returned to the UK, it was a natural fit for me to join Fitzpatrick Referrals. The team all share the same ethos and together I know we will be able to offer a truly world-class service to our patients and their family. I genuinely believe we will be able to change what is accepted as the gold standard of care for animals in the UK."
Fitzpatrick Referrals says its interventional radiology service performs minimally invasive procedures that are often considered the standard of care in human medicine, providing options for veterinary patients where conventional therapies are not associated with the best outcome.
Clinical Director of Oncology and Soft Tissue, Professor Nick Bacon said: "Gerard joining the team in Guildford opens new doors for our patients but more importantly we hope the disciplines of veterinary oncology and soft tissue surgery as a whole. He brings huge experience in interventional radiology solutions for portosystemic shunts, tracheal collapse and urinary calculi obstruction. Gerard is also key to developing our cancer care. Progress is not about ever bigger treatments chasing a cure; it can just as easily mean delivering palliative or curative-intent treatments in smarter ways, with less side-effects and lower morbidity. I am looking forward to watching our treatments evolve for a variety of tumours including urinary, liver, lung and head and neck. No cancer treatment is perfect, but we are striving for the best we can for the patient in front of us."
Noel Fitzpatrick said: "It remains my objective to build the greatest team of super-specialists on planet earth where we can offer all of the options to all of the animals and the families that love them all of the time. Gerard has a unique skill set that will not only complement our growing team, but will enhance the spectrum of treatments we can offer and which the families of animals throughout the UK and beyond really want. Increasingly people want the same level of care for their dogs and cats as we have for ourselves and our goal is to deliver exactly that with the very best team and facilities in the world today."
Fitzpatrick Referrals will be holding a Partners in Care CPD session on 25th May inviting vets to meet Dr Gerard McLauchlan and discover more about the interventional radiology service. To register your interest, contact Sarah on SarahC@fitzpatrickreferrals.co.uk.
Each year, the company invites veterinary surgeons, practice managers and practice principals to enter the competition by telling them what makes their nurse or nursing team outstanding, and deserving of special thanks, at: http://www.glvets.com/thank-a-nurse.asp
In 2016, the winning nomination for an outstanding nurse was Louise Cornford (pictured right) from Withy Grove Veterinary clinic. Her manager said: "Louise works tirelessly in the practice promoting better standards for all our patients and is always around helping the students and advising them on inpatient care. She gives up her own time to come back and nurse overnight patients when clients have difficulty finding out-of-hours care for their pets. She is also a full-time mum to three children. She became a vet nurse as a career change studying whilst caring for the family and then went on to get an additional qualification in critical care."
The winning nurse team last year was from Ribble Vets. Their nomination read: "I would like to nominate my team of hard-working nurses for all the support they give to their colleagues, clients and especially the patients in their care. We have a wide age and experience range within the team and there is interest and expertise in surgical, medical, behavioural, rehabilitation and emergency nursing. Every patient counts and every nurse goes the extra mile on a daily basis. I am so proud of the team and they deserve a little thank you for all those bleary- eyed moments in the early hours dealing with an RTA, GDV, whelping or other emergency. They take it all in their stride - even the farm animal emergencies!"
Is your team, or a member of your team, deserving of a special thanks? If so, nominate them here: http://www.glvets.com/thank-a-nurse.asp
Mr Seymour-Hamilton was originally removed from the Register in June 1994 for failing to maintain his practice’s equipment and facilities in working order such that it evidenced a total disregard of basic hygiene and care for animals, thereby bringing the profession into disrepute.
The restoration hearing on Monday 15 May was Mr Seymour-Hamilton’s fifth application for restoration, with previous applications being submitted but refused in July 1995, June 2010, January 2015 and March 2016. However, as the Committee made its decision on the merits of the case before it, those previous applications were not considered as relevant to its decision.
Mr Seymour-Hamilton told the Committee that he currently works as a herbalist and naturopath for humans and wished to be restored to the Register so he could include animals in his research, citing his treatment of one of his dogs as evidence.
The Committee rejected his application on a number of grounds, including the impact on animal welfare should Mr Seymour-Hamilton be restored to the Register; the length of time he had been off the Register and the fact that he was therefore not up-to-date with contemporary veterinary practice and professional conduct; that his efforts to keep up-to-date in terms of knowledge, skills and developments in practice were insufficient; and his lack of evidence of public support for him or his work.
Ian Green, chairing the Committee and speaking on its behalf, said: "The Committee has very great concerns about the future of the welfare of animals in the event of the applicant being permitted to have his name restored to the Register. He has made it clear that whilst he has no intention to return to routine veterinary general practice, he would intend to treat animals and to continue his research using animals. The Committee observes that were he to be restored to the Register, there would be no power to prevent the applicant practising as a veterinary surgeon in any way he may choose."
He added: "The applicant has now been off the Register for nearly 23 years. It will be apparent to anyone that the veterinary profession today is in many respects different from what it was 23 years ago, (eg: in terms of medical understanding and its own regulation). The Committee is far from persuaded that the passage of 23 years has not had a negative impact on the applicant’s ability to practise safely and competently as a veterinary surgeon at this present time."
Jason (pictured right with Paul), said: "Let me tell you, that was hard! Nine days and 900km of mountain bike riding, with 250km technical single track and only about 10 km tar, but we did it! We are so proud to be able to contribute to a future for rhinos!"
The veterinary velocipedists were raising money for The Chipembere Foundation, which specialises in sourcing, testing and funding technology for monitoring rhinos. They fund K9 handlers and their tracking and apprehension dogs, as well as funding and providing anti-poaching teams with vital equipment needed to translocate rhinos across Southern Africa.
It costs about £38000 to translocate a rhino from South Africa to neighbouring Botswana where there is less poaching (for now). Satellite tracking leg collars cost £1500 with an annual service and VHF collars and transmitters costing around £220. Dog and dog handler training is in the region of around £5000 per dog and there are additional costs for kennels, transport vehicles and day to day items like bowls, brushes, leads etc.
If you want to support Jason and Paul in their efforts to make a positive difference to the plight of the fast-dwindling numbers of rhino, visit www.justgiving.com/teams/rhinocycle.
The charity will be carrying out a study about the disease in collaboration with the Universities of Liverpool and Nottingham. However, because funding for research is limited, and because researchers want it to answer questions around PPID that owners and veterinary surgeons actually want to know, they are asking for your suggestions.
The AHT says that it wants to provide owners and vets with practical and applicable advice that will improve the wellbeing of their horses, based on scientific evidence. So whether that’s a question around how the disease is diagnosed, the best way to treat it or what the long term prognosis is, now is your chance to have your say.
If you own or care for a horse/pony with PPID or are a veterinary surgeon that treats them (or you have done in the past) please visit: www.aht.org.uk/PPID, to take part.
If you have any questions, contact the Project Investigator Becky Tatum by email: becky.tatum @aht.org.uk or by telephone: 01638 751000 Ext. 1241
The National Equine Health Survey is an online snapshot survey designed to uncover common health issues in horses, directly from horse owners themselves. Results of the survey are used to build a picture of equine health and disease in the UK and define priorities for future research, training and education.
Over the past six years the survey, in partnership with the British Equine Veterinary Association, has developed to become one of the UK’s most important endemic disease monitoring initiative. The results are referenced in leading veterinary and equestrian publications and papers and are regarded as valuable benchmarks for our general knowledge of horse health.
Blue Cross Education Officer Gemma Taylor said: "These majestic police horses have taken part in our survey and we hope that they will encourage others to follow suit and be ambassadors for horse welfare.
"The more data we can collect from the National Equine Health Survey the more robust our results will be, helping us to steer equine awareness, education and research to keep our nation’s horses healthier."
Last year survey records were returned for almost 17,000 horses, ponies, donkeys and mules and the six most notable disease syndromes identified.
To take part in the National Equine Health Survey, visit: www.bluecross.org.uk/NEHS
To find out more about Blue Cross’s rescue and rehoming work with horses and ponies visit bluecross.org.uk
The company says that until now, veterinary surgeons wanting to protect pets against both lungworm and ticks have had to prescribe multiple products, often with different methods of administration and/or treatment frequencies, leading to potential client confusion and issues with compliance. Being able to use one beef-flavoured chew will, it says, make things much simpler.
NexGard Spectra contains afoxolaner, an isoxazoline effective against ectoparasites, and milbemycin oxime for lungworm prevention and the treatment of GI roundworms, such as Toxocara.
Merial highlights data which indicates an ever-increasing threat to dogs in the UK from lungworm and ticks: Angiostrongylus vasorum is spreading across the UK, with prevalence in foxes rising from 7% in 2005 to 18% in 20141,2. The risk of exposure to ticks has increased, with a recent study showing that nearly 1 in 3 dogs were found to host ticks3, compared to around 1 in 7 dogs in a previous study4. Cases of the potentially fatal tick-borne disease Babesiosis (carried by the tick vector Dermacentor reticulatus) are also being diagnosed in un-travelled UK dogs5.
Lynda Maris, NexGard Spectra Product Manager, says that the changing patterns mean both parasites have become higher priority risks in many practices: "Until now vets have had to recommend combinations of products, or make a choice about which parasite represents the greatest risk in their area – ticks or lungworm. But as both parasites have changed their behavior, the risk of exposure has increased across the country.
"Now just one tasty chew will address both lungworm and ticks, meaning that pet owners don’t have to concern themselves with administering different products and vets know that in the face of a rapidly changing situation there is a simple way to make sure their patients are protected."
The company also highlights a recent vet practice sampling campaign5, in which 79% of dogs took NexGard Spectra readily or like a treat. More than 90% of respondents to the survey said they would be likely or very likely to recommend it to their clients.
NexGard Spectra can be used from 8 weeks of age in puppies weighing more than 2 kgs, and is very well tolerated, including by MDR-1 mutant collies, where studies showed no treatment-related changes even at five times the maximum dose. It is available in packs of three chews, with five different presentations to ensure accurate dosing according to bodyweight (2-3.5 kgs, 3.5-7.5 kgs, 7.5-15 kgs, 15-30 kgs and 30-60 kgs).
For more information, contact your Merial Territory Manager, call Merial on 0870 6000 123, or visit www.nexgardspectra.co.uk.
References:
The company says ligation clips, used to clamp vessels, have been used in complex surgeries on humans (including heart surgeries) since the 1980’s, but have only been introduced in veterinary practice in recent years.
Vet Direct has been showcasing the clips at the recent BSAVA and AVA shows, and says it has been surprised at the level of interest in the product.
Leon Wright, managing director at Vet Direct, said: "The ligation clips caused a big noise at our recent events, which is probably down to the benefits they offer. Not only are they quicker and easier, you get immediate vessel closure which reduces the amount of time a patient has to endure under general anesthetic. I’m confident that they’ll be a great help to all veterinary surgeons."
The company says it has already seen several clients make use of the clips, most frequently in common surgeries such as splenectomies and cholecystectomies.
For more information, visit www.vet-direct.com or call 0800 068 3300.
The study1, which was conducted in collaboration with Plymouth University, sought to find out what influences owners to buy a flat-faced breed, and once this decision has been made, how they go about acquiring a puppy. The study surveyed owners of the top 10 most popular Kennel Club registered breeds in the UK, to compare how influences upon breed choice and purchasing processes differed between owners of flat-faced breeds and popular longer-faced breeds.
Appearance was found to be the number one reason owners purchase flat-faced breeds, attracted by their large, round, wide-set eyes, and flat rounded faces. However, such characteristics are linked with lifelong respiratory, eye and skin problems, and a reduced lifespan compared with longer-faced breeds.
Key influencing factors associated with the choice of a brachycephalic breed included:
When it came to buying a flat-faced dog, owners were:
Dr Rowena Packer, lead author of the study and Research Fellow at RVC, said: "With their small size and baby-like features, some people cannot resist the looks of a brachycephalic dog. With growing evidence that these breeds are faced with a range of chronic and severe health conditions directly linked with their appearance, it is of huge concern that many people drawn to these breeds prioritise a dog’s looks over their long-term health and wellbeing.
"Potential puppy buyers attracted to the appearance of these breeds should seriously consider whether they are emotionally and financially prepared to take on a breed with high risks of health complications, and consider whether alternative, lower-risk breeds would better fit their lifestyle."
Co-author of the study and Associate Professor of Animal Welfare at Plymouth University, Dr Mark Farnworth, said: "Owners must be aware that as puppy-buyers, they are consumers, and their choices affect not only the health of the puppy they purchase, but also the health of the breed more widely. If owners do not follow recommended processes when purchasing a puppy, for example those set out in BVA AWF & RSPCA ‘Puppy Contract’, unscrupulous breeders will be kept in business, and continue to profit from the breeding and sale of unhealthy dogs. Without consumer awareness, breed health improvements are not possible and the overall health of these breeds will likely decline."
Paula Boyden, Dogs Trust Veterinary Director said: "The increased popularity of breeds such as Pugs, French Bulldogs and English Bulldogs is a huge welfare concern, particularly as this research indicates that the health of the breed was not a major consideration for potential puppy buyers. Many people mistakenly believe that the breathing sounds these breeds often make are endearing traits, rather than an indication of respiratory problems associated with their conformation. Dogs Trust urges anyone thinking of getting a puppy to look beyond the appearance of a breed, understand the impact on health, research the seller and buy responsibly."
Researchers say that the French Bulldog is set to become the most registered dog in 2017, overtaking the Labrador Retrievers’ 27-year reign at the top. The study therefore makes a number of recommendations, including:
Photo: Wikipedia CC BY-SA 3.0 Credit: Cristorresfer
The PAW Report, which monitors pet welfare issues across the UK, is produced in conjunction with YouGov. Over 63,000 pet owners have been surveyed since 2011, providing the most robust insight into the welfare of UK pets.
For the first time, each section of the report ends with a veterinary action area that highlights the main issues, suggests what veterinary surgeons and nurses can do to tackle them, and lists resources that are available to help.
This year's PAW Report shows that just 75% of dogs (7.0 million) and 65% of cats (6.7 million) received a primary vaccination course when young. These are the lowest levels ever recorded by the Report and compares with 82% of dogs and 72% of cats in 2011.
Only 66% of owners (5.6 million cats, 7.3 million dogs, 500,000 rabbits) surveyed in 2017 have protected their pet with annual booster vaccinations.
Rabbits remain the most neglected with only 50% receiving a primary vaccination when young, a decrease from 63% in 2016, and 55% not receiving their annual booster vaccinations.
PDSA Head of Pet Health and Welfare, Nicola Martin, said: "The decreasing number of dogs, cats and rabbits receiving primary and booster vaccinations is a great concern for the health and welfare of the nation's pets."
20% of both dog and cat owners and 10% of rabbit owners who hadn't vaccinated their pets gave 'too expensive' as their reason for not vaccinating.
Nicola added: "While the latest PAW Report confirms that many of us get pets for the companionship and love they bring to our lives, it also highlights many owners continue to misjudge the costs involved in owning a pet. Despite potential lifetime costs of dog ownership easily rising to £21,000, the Report revealed 98% of dog owners surveyed estimated that their dog would cost less than this over the dog’s lifetime. This shows that the veterinary profession and animal welfare organisations need to do more to raise awareness of the financial reality of pet ownership – including preventive care and veterinary treatment – before owners take on a pet."
Of those owners who hadn't vaccinated their pets, 14% of dog owners, 22% of cat owners and 32% of rabbit owners felt vaccinations were unnecessary. 24% of pet owners who hadn’t vaccinated their pets said that this is because their pet didn’t come into contact with other pets.
Nicola continued: "These findings show there’s a real lack of knowledge of the devastating diseases pets are susceptible to if they’re not protected through vaccination. It’s important we improve vaccination levels before we face a resurgence of pets suffering with vaccine-preventable diseases."
John Chitty, President of the BSAVA said: "The current vaccination levels in cats and rabbits are far below the levels expected to provide a 'herd immunity effect' with the consequence that significant reductions in these diseases are further away, and those pets not vaccinated are at even greater risk.
"In particular it is deeply worrying to see the fall in vaccinated rabbits. The recent advances in myxomatosis vaccines mean that it is now much easier and cheaper to ensure more complete protection of pet rabbits from what is a common and lethal disease. The advent of RHD-2 virus in the last couple of years also seems to have failed to stimulate more owners seeking vaccination for their rabbits, especially given the publicity that this has generated."
In response to the report findings, the PDSA is launching ‘Spread the word, not the disease’, a campaign to help raise awareness, spread the word about preventable deadly diseases, and encourage pet owners to get their pets vaccinated and ensure their boosters are up-to-date.
The PDSA is asking people to pledge their support at: www.pdsa.org.uk/spreadtheword
Nicola concluded: "It’s up to the veterinary profession to help educate pet owners on the importance and value of vaccination. This is an area which requires collaboration and a co-ordinated effort across veterinary bodies to ensure owners can make informed decisions about vaccination. By launching this campaign, we hope to raise awareness of the risks these diseases pose, and how important vaccinations are in protecting the long-term health and wellbeing of the nation’s pets."
The full report can be downloaded here: https://www.pdsa.org.uk/get-involved/our-current-campaigns/pdsa-animal-wellbeing-report
About the PAW Report
All figures, unless otherwise stated, are from YouGov Plc. Total sample size was 4,153 dog, cat and rabbit owners aged 18+ who live in the UK. Fieldwork was undertaken between 23 February and 6 March 2017. The survey was carried out online. The figures have been weighted and are representative of the population by pet species (cat, dog or rabbit owners) and the owner’s gender, age and region.
Extrapolations to pet population figures are based on the following estimates of pet populations in the UK: 9.3 million dogs, 10.3 million cats, and 1.1 million rabbits.
Whilst declawing is illegal in many countries of the world, it remains surprisingly common in others, including North America, where it is performed electively to stop cats from damaging furniture, or as a means of avoiding scratches.
The operation to declaw does not just remove the claw, but also the end bone of the toe. Previous research has focused on short-term issues following surgery, such as lameness, chewing of toes and infection, but the long-term health effects of this procedure have not to date been investigated.
For the study, the author group, based in North America, investigated a total of 137 non-declawed cats and 137 declawed cats, of which 33 were declawed on all four feet. All 274 cats were physically examined for signs of pain and barbering (excessive licking or chewing of fur) and their medical history was reviewed for unwanted behaviours.
They found that inappropriate toileting, biting, aggression and over-grooming occurred significantly more often in the declawed cats than the non-declawed cats (roughly 7, 4, 3 and 3 times more often, respectively, based on the calculated odds ratio).
A declawed cat was also almost 3 times more likely to be diagnosed with back pain than a non-declawed cat (potentially due to shortening of the declawed limb and altered gait, and/or chronic pain at the site of the surgery causing compensatory weight shift to the pelvic limbs).
International Cat Care has issued a position statement saying that even if surgical techniques were improved to negate some of the adverse effects of declawing, it would remain of the opinion that the procedure is unethical other than if required to manage a medical condition, and should be legislated against wherever possible.
The referral centre recently extended its floor space at its base in Cheshire to support a major expansion of the services being offered, which include orthopaedic, soft tissue and spinal surgery and internal medicine; with specialist support in anaesthesia and pain management, a diabetes clinic, intensive care, cardiology, diagnostic imaging, neurology (medical and surgical) and oncology.
Liz Cousins, hospital manager at Northwest Veterinary Specialists, said: "The success of NWVS is down to the dedication of our highly skilled clinical, nursing and support teams.
"Our clinicians are well respected specialists in their chosen disciplines and it’s fantastic to be able to offer new services to pets and first opinion vets.
"The hospital is home to 88 colleagues and the change of name now reflects the growth and dedication by everyone here at Northwest Veterinary Specialists since opening in 2002."
Northwest Veterinary Specialists provides specialist veterinary services to veterinary practices in north west England and north and mid Wales.
Liz added: "At Northwest Veterinary Specialists we treat pets from as far apart as Carlisle, North Yorkshire and Staffordshire.
"The facilities are state-of-the-art, demonstrating a quality of service both for our clinicians and our clients, but most importantly the pets that we treat."
Bayer Animal Health, maker of Advocate, says that since February, veterinary surgeons have reported more than 80 cases of canine lungworm infection in the UK, of which six have died.
The fatal cases were reported in Salisbury, Crawley, Ipswitch and Essex.
Of the 84 cases reported, 43 practices said it wasn't their first. With no requirement for compulsory reporting, Bayer says it is likely that other cases have gone undocumented.
Although the majority of cases reported to Bayer were found in the South of the UK, others were reported as far north as Paisley in Scotland. This, says the company, adds to the increasing base of evidence that lungworm is endemic throughout much of the UK and continues to pose a significant threat to dogs.
Recent research by Bayer found that 37% of veterinary surgeons thought cases of lungworm had increased in their area over the last five years.2
The company also points towards a study from the University of Bristol which examined the fox population and found further evidence of the parasite's spread across the UK.3 The research suggests that the overall prevalence of A.vasorum in foxes is 18.3% in the UK, significantly higher than a previous study published in 2008, which reported a prevalence of 7.3%.3
The South East is reported to have the highest prevalence, with 50% of foxes now found to be infected (more than double the previous figure). In the North of England and Scotland, 7.4% of foxes were found to be infected despite none being found in this region in the earlier study.
Dogs which have picked up a lungworm infection can show a number of different symptoms including breathing difficulties, a lack of energy, coughing and persistent bleeding. However, the clinical signs can be varied and some dogs may appear healthy in the early stages of infection.
Gavin McAulay, a cardiorespiratory specialist at New Priory Veterinary Hospital in Brighton said: "With often confusing symptoms, the clinical judgement of vets is key in ensuring an animal is diagnosed and treated against lungworm as soon as possible. In many scenarios lungworm should be a consideration to be assessed in the background whilst investigating other conditions, however monthly prevention is key. There is evidence with other parasite diseases that suggests the more animals you treat, the better protected other animals in the area are."
Bayer’s 'Act Against Lungworm' campaign is urging veterinary surgeons to encourage monthly lungworm preventative treatment. Prevention which stops larval shedding will also help limit the geographical spread of the disease.
Donna Tomlinson, Senior Product Manager for Advocate said: “With the continued spread of lungworm in the UK, it is important to ensure that our 2017 ‘Act Against Lungworm’ campaign resonates with local communities. We have the case studies to show that lungworm has been reported across the UK, but we rely on the support of vets to help get the message out.
"This year we are putting local vets at the center of our communications, with dedicated campaigns planned in every region. This is a great opportunity for practices to get involved in a local media campaign, talk about their first-hand experiences with the parasite and encourage pet owners to visit them for advice on preventative treatment.”
Veterinary surgeons can report cases to their local Bayer Territory Manager or practices can log their own incidences directly by emailing lungworm@bayer.com.
'Act Against Lungworm' veterinary campaign materials are available for practices to display in waiting rooms, as well as leaflets to assist practitioners in communicating to dog owners the importance of protecting their pet against lungworm. These can be ordered at the Bayer Vet Centre (www.vetcentre.bayer.co.uk).